Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Two Arm, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19.

NCT04353518 is registered in ClinicalTrials.gov with Cadila Pharnmaceuticals as lead sponsor.

NCT NCT04353518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04353518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Two Arm, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19.
Lead sponsor
Cadila Pharnmaceuticals
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2020
Completion date
May 30, 2021
Enrollment
4,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19